Title | Description |
|---|---|
| Trial ID | AV001 |
| Compound | Capsaicin 8% |
| Trials sponsor | Averitas Pharma, Inc |
| Trial phase | 3 |
| Brief title | Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery (RISE) |
| Indication | Neuropathic pain |
| UTN | U1111-1272-1340 |
| CTG ID | NCT04967664 |
| CTIS ID (former EudraCT) | 2024-514934-19-00 |
| Trial status | Completed |
| FPI | July 13, 2021 |
| LPO | August 28, 2025 |
| Countries | United States of America, United Kingdom, France, Poland, Spain, Netherlands |
| Gender | All |
| Age | >= 18 years of age |
| Results | No |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.